A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer

BACKGROUND AND OBJECTIVES: Endometrial cancer is a common malignancy and recurrences can be fatal. Although platinum-pretreated endometrial tumors are commonly treated with anthracyclines and taxanes, there is no current standard of care. Both immune checkpoint inhibitors (ICIs) and tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinker, Anna V., Dhani, Neesha C., Ghatage, Prafull, McLeod, Deanna, Samouëlian, Vanessa, Welch, Stephen A., Altman, Alon D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Immunotherapy in Gynecological Cancers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026109/
https://www.ncbi.nlm.nih.gov/pubmed/36950270
http://dx.doi.org/10.1177/17588359231157633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026109/
https://www.ncbi.nlm.nih.gov/pubmed/36950270
http://dx.doi.org/10.1177/17588359231157633

Ejemplares similares